[Research Progress on Chimeric Antigen Receptor T Cells-Review].

Rui-Meng Zhuang1, Jian Cheng1

  • 1Southeast University Medical College, Department of Hematology of Zhongda Hospital Affiliated to Southeast University, Nanjing 210009, Jiangsu Province, China.

Summary

Chimeric antigen receptor T cell (CAR-T) therapy shows promise for treating advanced cancers by targeting tumor antigens. Despite successes, challenges remain, driving ongoing research into CAR-T development and future trends.

Related Concept Videos